The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Some stimulatory receptors of the innate immune system, such as the NKG2D receptor (also called KLRK1) expressed by natural killer cells and activated CD8(+)T cells, recognize self-molecules that are upregulated in diseased cells by poorly understood mechanisms. Here we show that mouse and human NKG2D ligands are upregulated in non-tumour cell lines by genotoxic stress and stalled DNA replication, conditions known to activate a major DNA damage checkpoint pathway initiated by ATM (ataxia telangiectasia, mutated) or ATR (ATM- and Rad3-related) protein kinases. Ligand upregulation was prevented by pharmacological or genetic inhibition of ATR, ATM or Chk1 (a downstream transducer kinase in the pathway). Furthermore, constitutive ligand expression by a tumour cell line was inhibited by targeting short interfering RNA to ATM, suggesting that ligand expression in established tumour cells, which often harbour genomic irregularities, may be due to chronic activation of the DNA damage response pathway. Thus, the DNA damage response, previously shown to arrest the cell cycle and enhance DNA repair functions, or to trigger apoptosis, may also participate in alerting the immune system to the presence of potentially dangerous cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In addition, genomic damage—a common cause of cellular senescence—induces expression of the membrane-bound ligands for the major natural killer cell receptor NKG2D (140).”
From Aging, Cellular Senescence, and Cancer (2013) · cites this paper as [140]
The cited source says what the claim attributes to it.
In the citing paper
“other evidence indicates that the immune system's recognition of tumour cells might require the continuous activation of the DDR pathway 13”
From The common biology of cancer and ageing (2007) · cites this paper as [13]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Further, DNA damage or activation of oncogenes can induce cellular senescence, through a pathway that relies, in part, on the secretion of pro-inflammatory cytokines such as insulin-like growth factor binding protein-7 (IGFBP7)32 and IL-633, and on the secretion of CXC-chemokine ligand 8 (CXCL8) and other chemokines 33,34, as well as on the expression of the CXCL8 receptor CXC-chemokine receptor 2”
From Immunogenic and tolerogenic cell death (2009) · cites this paper as [32]
Experimental — accuracy not yet measuredIn the citing paper
“These findings are consistent with previous studies suggesting that NKG2D ligands are induced by a variety of other stimuli, including E2F transcription factors, PI3 kinase, Ras oncogene signaling, and an activated DNA damage response (Gasser et al., 2005; Tokuyama et al., 2011; Jung et al., 2012).”
From p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells (2013) · cites this paper as Gasser et al., 2005
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: p73α Regulation by Chk1 in Response to DNA Damage
Gonzalez, S., Prives, C., & Cordon-Cardo, C. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.22.8161-8171.2003 · Cited by 75
RetractedDNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation
Bakkenist, C. J., & Kastan, M. B. (2003) · Nature · doi:10.1038/nature01368 · Cited by 3,466
Molecular Mechanisms of Mammalian DNA Repair and the DNA Damage Checkpoints
Sancar, A., Lindsey-Boltz, L. A., Ünsal-Kaçmaz, K., & Linn, S. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.011303.073723 · Cited by 3,317
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
Bartkova, J., Hořejší, Z., Koed, K., Krämer, A., Tort, F., Zieger, K., Guldberg, P., Sehested, M., Nesland, J. M., Lukas, C., et al. (2005) · Nature · doi:10.1038/nature03482 · Cited by 2,688
Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions
Gorgoulis, V. G., Vassiliou, L.-V. F., Karakaidos, P., Zacharatos, P., Kotsinas, A., Liloglou, T., Venere, M., DiTullio, R. A., Kastrinakis, N. G., Levy, B., et al. (2005) · Nature · doi:10.1038/nature03485 · Cited by 2,009
Cell cycle checkpoint signaling through the ATM and ATR kinases
Abraham, R. T. (2001) · Genes & Development · doi:10.1101/gad.914401 · Cited by 1,966
Chk1 and Chk2 kinases in checkpoint control and cancer
Bartek, J., & Lukas, J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00110-7 · Cited by 1,513
Roles of the NKG2D immunoreceptor and its ligands
Raulet, D. H. (2003) · Nature Reviews Immunology · doi:10.1038/nri1199 · Cited by 1,348
Self-citation(1999) · PubMed · Cited by 1,030
ATR disruption leads to chromosomal fragmentation and early embryonic lethality
Brown, E. J., & Baltimore, D. (2000) · Genes & Development · doi:10.1101/gad.14.4.397 · Cited by 951
Self-citation
Cited by
Items 801–900 of 1,000
The Modulation of the Cell-Cycle: A Sentinel to Alert the NK Cells of Dangers
Baychelier, F., & Vieillard, V. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00325 · Cited by 21
γδ T Cells as a Potential Tool in Colon Cancer Immunotherapy
Ramutton, T., Buccheri, S., Dieli, F., Todaro, M., Stassi, G., & Meraviglia, S. (2014) · Immunotherapy · doi:10.2217/imt.14.59 · Cited by 20
Basher, F., Jeng, E. K., Wong, H. C., & Wu, J. D. (2015) · Oncotarget · doi:10.18632/oncotarget.6416 · Cited by 24
“Ligand-induced activation of the NK cell activating receptor NKG2D has been demonstrated to be significant in controlling tumor growth in experimental animal models [1, 2].”
Djelloul, M., Popa, N., Pelletier, F., Raguénez, G., & Boucraut, J. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.07.147 · Cited by 20
“Moreover, DNA damage is responsible for NKG2D ligands induction, including RAE-1, in numerous tumor cell lines and after genotoxic drugs treatment (Gasser et al., 2005; Cerboni et al., 2007).”
A critical discussion on diet, genomic mutations and repair mechanisms in colon carcinogenesis
Sakita, J. Y., Gasparotto, B., Garcia, S. B., Uyemura, S. A., & Kannen, V. (2016) · Toxicology Letters · doi:10.1016/j.toxlet.2016.11.020 · Cited by 24
Li, D., Hu, M., Liu, Y., Du, P., Du, P., Li, C.-S., Cheng, L., Liu, P., Jiang, J., Su, L., et al. (2018) · Cell Discovery · doi:10.1038/s41421-017-0007-9 · Cited by 20
Immunity, immunotherapy, and rectal cancer: A clinical and translational science review
Otegbeye, E. E., Mitchem, J. B., Park, H., Chaudhuri, A. A., Kim, H. J., Mutch, M. G., & Ciorba, M. A. (2020) · Translational research · doi:10.1016/j.trsl.2020.12.002 · Cited by 23
Adaptive Subsets Limit the Anti-Tumoral NK-Cell Activity in Hepatocellular Carcinoma
Rennert, C., Tauber, C., Fehrenbach, P., Heim, K., Bettinger, D., Sogukpinar, O., Schuch, A., Zecher, B. F., Bengsch, B., Lang, S. A., et al. (2021) · Cells · doi:10.3390/cells10061369 · Cited by 21
“DNA-damage response 23 induced NKG2D ligands on tumor cells [10, 11]).”
BackgroundTullio, G. D., Strippoli, S., Angarano, R., de Fazio, V., Sgherza, N., Negri, A., Albano, A., Iacopino, P., Guarini, A., & Guida, M. (2015) · Journal of Translational Medicine · doi:10.1186/1479-5876-13-s1-o10 · Cited by 20
The role of NK cells in regulating tumorimmunity: current state, challenges and future strategies
Zhu, W., Fan, C., Zhao, Y., Li, W., Niu, J., Dong, S., Yang, Z., & Zhou, W. (2025) · Cancer Cell International · doi:10.1186/s12935-025-03980-y · Cited by 19
“This receptor-ligand system assumes significant importance due to the upregulation of ligands in response to DNA damage and cGAS-STING signaling, a phenomenon seldom observed in healthy cells [190, 191] (Fig.”
An, M., Yan, J., Liu, B., & Liu, Q. (2026) · 癌症:英文版 · doi:10.34133/cancomm.0023 · Cited by 20
“In addition, radiation-induced DNA damage can up-regulate NKG2D ligands on tumor cells, heightening NK cell activation and cytotoxicity, a pathway that could be leveraged by NKG2D-based CAR-NK designs [ 189 , 190 ].”
Natural killer NKG2A and NKG2D in patients with colorectal cancer
Meckawy, G. R., Mohamed, A. M., Zaki, W. K., Khattab, M. A., Amin, M. M., Eldeeb, M. A., Rushdy, M., & Safwat, N. A. (2019) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo.2018.12.13 · Cited by 19
“NKG2D ligands are not demonstrated on normal cells, however on solid tumors and few types of leukemia through induction of cancer-related pathways and oncogenes (12,13).”
BackgroundWang, J., Liu, K., Xiao, T., Liu, P., Prinz, R. A., & Xu, X. (2022) · OncoImmunology · doi:10.1080/2162402x.2021.2016159 · Cited by 21
“In particular, genotoxic drugs stimulate MICA/B expression on fast proliferating fibroblasts and tumor cells by activating the ATM-Chk pathway.(9) This pathway is primarily responsible for repairing DNA double-strand breaks and for phosphorylating p53 and CDC25A to halt cell cycle progression.”
BackgroundPhoton- and Proton-Mediated Biological Effects: What Has Been Learned?
Jumaniyazova, E. D., Смык, Д., Vishnyakova, P., Fatkhudinov, T., & Gordon, K. B. (2022) · Life · doi:10.3390/life13010030 · Cited by 19
“Tumor cell exposure to ionizing radiation in vitro promoted them from expressing specific ligands to NKG2D—an activating receptor on NK cells [30,31].”
BackgroundPatient Assessment and Therapy Planning Based on Homologous Recombination Repair Deficiency
Li, W., Gao, L., Yi, X., Shi, S., Huang, J., Shi, L. M., Zhou, X., Wu, L., & Ying, J. (2023) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2023.02.004 · Cited by 20
“Moreover, BRCA deficiency was related to elevated PD-L1 expression [66,67] and T-cell infiltration in ovarian cancers [66].”
Backgrounddel Toro‐Arreola, S., Arreygue-Garcia, N., Aguilar‐Lemarroy, A., Arregui, A. C., Jiménez-Pérez, M. I., Haramati, J., Barros‐Núñez, P., González‐Ramella, O., Toro‐Arreola, A. D., Ortiz‐Lazareno, P. C., et al. (2011) · Cancer Cell International · doi:10.1186/1475-2867-11-15 · Cited by 19
“The molecular mechanisms involved in the expression of MICA and MICB are still poorly understood; however, experimental evidence has revealed that their over-expression is the result of a DNA damage response that involves the ATM (ataxia telangiectasia mutated) and the ATR (ATM- and Rad3related) protein kinases [21,22…”
BackgroundHuman Herpesviridae Methods of Natural Killer Cell Evasion
Odom, C. I., Gaston, D. C., Markert, J. M., & Cassady, K. A. (2012) · Advances in Virology · doi:10.1155/2012/359869 · Cited by 19
Human NK Cells Downregulate Zap70 and Syk in Response to Prolonged Activation or DNA Damage
Pugh, J. L., Nemat‐Gorgani, N., Norman, P. J., Guethlein, L. A., & Parham, P. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1700542 · Cited by 19
Oncogenes in immune cells as potential therapeutic targets
Zakiryanova, G. K., Wheeler, S., & Shurin, M. R. (2018) · ImmunoTargets and Therapy · doi:10.2147/itt.s150586 · Cited by 21
“Mouse and human NKG2D ligands can be upregulated in nontumor cell lines by genotoxic stress and stalled DNA replication, conditions known to activate a major DNA damage checkpoint pathway initiated by ATM or ATR protein kinases.(40) Thus, the DNA damage response may participate in activation of the immune system (part…”
Partanen, J., Hyvärinen, K., Bickeböller, H., Bogunia‐Kubik, K., Crossland, R. E., Ivanova, M., Perutelli, F., & Dressel, R. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.575492 · Cited by 21
Tumor Microenvironment and Immune Effects of Antineoplastic Therapy in Lymphoproliferative Syndromes
Álvaro, T., de la Cruz‐Merino, L., Henao‐Carrasco, F., Rodríguez, J. L. V., Baz, D. V., de Villena, M. C. M., & Provencio, M. (2010) · BioMed Research International · doi:10.1155/2010/846872 · Cited by 19
“NKG2D acts as an activating receptor on NK cells, γδ T cells, NKT cells, and memory CD8+ T cells, giving raise to the possibility that DNA damage response may induce immune system activation [68, 73].”
BackgroundRussell, P. S., Chase, C. M., Madsen, J. C., Hirohashi, T., Cornell, L. D., Sproule, T. J., Colvin, R. B., & Roopenian, D. C. (2011) · Transplantation · doi:10.1097/tp.0b013e3182122f82 · Cited by 19
“Type I and II interferons suppress H60 on tumor cells (28), whereas stress stimuli, such as DNA damage and apoptotic responses, upregulate NKG2D ligands (20).”
BackgroundChen, Z., Li, Z., Chang, Y., Ma, L., Wenhu, X., Li, M., Li, J., Zhang, W., Sun, Q., An, X., et al. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.04.025 · Cited by 19
Distinct Mechanisms of Tumor Resistance to NK Killing: Of Mice and Men
Pardoll, D. M. (2015) · Immunity · doi:10.1016/j.immuni.2015.04.007 · Cited by 19
“…diverse—a common thread among the even more diverse KAR ligands is that they are upregulated by various forms of cellular stress ranging from highly activated Ras-pathway signaling and DNA damage responses, both of which are common in many cancers (Raulet and Guerra, 2009; Gasser et al., 2005).”
BackgroundDNA Mismanagement Leads to Immune System Oversight
Coscoy, L., & Raulet, D. H. (2007) · Cell · doi:10.1016/j.cell.2007.11.012 · Cited by 19
“…such that Trex1 deficiency leads to chronic activation of DNA-sensing receptors of the innate immune system. lines, induces cell-surface expression of ligands that engage the NKG2D stimulatory receptor expressed by natural killer (NK) cells and certain T cell populations (Gasser et al., 2005).”
BackgroundSelf-citationZhao, L., Wang, W.-J., Zhang, J.-N., & Zhang, X. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.9.4039 · Cited by 19
“As described in the theory of Gasser (Gasser et al., 2005; Gasser et al., 2006): 5-FU+IL-2 immunochemotherapy induced DNA damage, which activated stress response molecules (ATM and ATR) and a variety of effector molecules downstream.”
BackgroundInfluentialBattle of the midgets: Innate microRNA networking
Elias, S., & Mandelboim, O. (2012) · RNA Biology · doi:10.4161/rna.19717 · Cited by 19
“The NKG2D receptor recognizes 8 different ligands (MICA, MICB and ULBP 1–6) whose expression is induced by various stresses such as virus infection(11) and tumor transformation.(12) Since cellular upregulation of NKG2D ligands signifies danger to the immune system, it is expected that these proteins would be manipulat…”
BackgroundAdenovirus vector delivery stimulates natural killer cell recognition
Tomasec, P., Wang, E. C. Y., Groh, V., Spies, T., McSharry, B. P., Aicheler, R. J., Stanton, R. J., & Wilkinson, G. W. G. (2007) · Journal of General Virology · doi:10.1099/vir.0.82685-0 · Cited by 18
“This property renders NKG2D particularly adept at identifying stressed cells, as its ligands can potentially be differentially upregulated by infection (viral or bacterial), DNA damage or heat shock (Bauer et al., 1999; Gasser et al., 2005; Groh et al., 1996, 1998, 2001).”
BackgroundImplications of a ‘Third Signal’ in NK Cells
Khalil, M., Wang, D., Hashemi, E., Terhune, S. S., & Malarkannan, S. (2021) · Cells · doi:10.3390/cells10081955 · Cited by 19
“Cellular stress conditions such as oncogenic proliferation, viral infection, or hypoxic microenvironment upregulate ligands for NKG2D [42].”
BackgroundThe Natural Killer Cell Cytotoxic Function Is Modulated by HIV-1 Accessory Proteins
Sowrirajan, B., & Barker, E. (2011) · Viruses · doi:10.3390/v3071091 · Cited by 18
“ATR and not ATM is phosphorylated and activated during HIV-1 infection by the viral protein Vpr [88,91].”
BackgroundInfluentialThe TGF ‐β‐induced up‐regulation of NKG 2 DL s requires AKT / GSK ‐3β‐mediated stabilization of SP 1
Chen, X., Lu, L., Ke, H., Liu, Z., Wang, H., Wei, W., Qi, Y., Wang, H., Cai, S., & Du, J. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13025 · Cited by 20
Tremblay-McLean, A., Bruneau, J., Lebouché, B., Lisovsky, I., Song, R., & Bernard, N. F. (2017) · Viruses · doi:10.3390/v9100295 · Cited by 18
“The expression of these ligands is induced by cellular stress and they are otherwise not found on the surface of healthy cells [11].”
BackgroundThe roles of homologous recombination and the immune system in the genomic evolution of cancer
Nandi, B., Talluri, S., Kumar, S., Yenumula, C., Gold, J. S., PRABHALA, R. H., Munshi, N. C., & Shammas, M. A. (2018) · Journal of Translational Science · doi:10.15761/jts.1000282 · Cited by 19
“In addition to inducing production of pro-inflammatory signals such as IFNs, replicative stress and DDR can also induce the expression of a number of ligands for activating immune receptors such as natural killer group 2, member D (NKG2D) and DNAX accessory molecule 1 (DNAM-1), which are mainly expressed by cytotoxic…”
BackgroundImmunosurveillance of cancer cell stress
Lorenzo‐Herrero, S., Sordo‐Bahamonde, C., Gonzalez, S. R., & López‐Soto, A. (2019) · Cell Stress · doi:10.15698/cst2019.09.198 · Cited by 19
“tion and lysis of the affected cells [125].”
Al-Abdallah, A., Jahanbani, I., Mehdawi, H., Ali, R. H., Al-Brahim, N., Mojiminiyi, O. A., & Junaid, T. A. (2020) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2020.104379 · Cited by 21
Mellergaard, M., Høgh, R. I., Lund, A., Aldana, B. I., Guérillot, R., Møller, S. H., Hayes, A. S., Panagiotopoulou, N., Frimand, Z., Jepsen, S. D., et al. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.012673 · Cited by 18
“Regulation of NKG2D ligands have been coupled to DNA damage and reactive oxygen species production often mediated by external stressors (9, 12, 71), but it has not previously been linked to an immune-metabolic mechanism in human monocytes.”
BackgroundCheng, S., Cheadle, E. J., & Illidge, T. (2020) · Cancers · doi:10.3390/cancers12102835 · Cited by 20
“RT can also upregulate MHC class I molecules, leading to enhanced recognition of tumour cells by cytotoxic T cells, and increased NKG2D expression may result in greater NK cell-mediated eradication of tumours [21,23].”
BackgroundPlaza-Rojas, L., & Guevara-Patino, J. A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.624131 · Cited by 32
“Of significance, proinflammatory signals such as IFN-α (30) and TLR4 and TLR7/8 signaling (28), as well as the ataxia telangiectasia mutated and Rad3-related (ATM/ATR) DNA damage response pathway also result in surface expression of these ligands (20, 27, 31, 32).”
BackgroundDNA Damage Response in the Adaptive Arm of the Immune System: Implications for Autoimmunity
Manolakou, T., Verginis, P., & Boumpas, D. T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115842 · Cited by 23
“Yet, human and mouse data in the context of cancer [91] suggest that NKG2D ligand overexpression detected in tumor cells may be due to chronic activation of the DDR in order to trigger the immune system.”
BackgroundUddin, M. B., Roy, K. R., Hill, R. A., Roy, S. C., Gu, X., Li, L., Zhang, Q.-J., You, Z., & Liu, Y. (2022) · Experimental Cell Research · doi:10.1016/j.yexcr.2022.113210 · Cited by 19
Concepts of immunotherapy for glioma
Patel, M. A., & Pardoll, D. M. (2015) · Journal of Neuro-Oncology · doi:10.1007/s11060-015-1810-5 · Cited by 19
“environment, and the antigens released by apoptotic tumor cells provide an immunogenic substrate for anti-tumor inflammation [71-75].”
The disposable soma theory of aging in reverse
Douglas, P. M., & Dillin, A. G. (2013) · Cell Research · doi:10.1038/cr.2013.148 · Cited by 18
Ohashi, M., Eagle, R. A., & Trowsdale, J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.077636 · Cited by 18
The innate immune system as mediator of systemic DNA damage responses
Ermolaeva, M., & Schumacher, B. (2013) · Communicative & Integrative Biology · doi:10.4161/cib.26926 · Cited by 21
“Additionally, replication fork stalling and genotoxic stress leads to induction of ligands for the NKG2D receptor that is expressed on natural killer cells.(14) The human innate Figure 1.”
BackgroundDNA damage response and development of targeted cancer treatments
Gasser, S. (2007) · Annals of Medicine · doi:10.1080/07853890701436773 · Cited by 18
“We observed that inhibiting ATM, ATR, or Chk1 in tumor cell lines led to a substantial decrease in Rae1 levels at the cell surface (8,11).”
BackgroundSelf-citationAPOBEC3 proteins and genomic stability: The high cost of a good defense
Narvaiza, I., Landry, S., & Weitzman, M. D. (2012) · Cell Cycle · doi:10.4161/cc.11.1.18706 · Cited by 18
Lim, K., Mimura, K., Kua, L., Shiraishi, K., & Kono, K. (2018) · Journal of Immunotherapy · doi:10.1097/cji.0000000000000227 · Cited by 20
Lee, Y., Heo, W., Son, C., Kang, C., Park, Y.-S., & Bae, J. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10583 · Cited by 19
Overcoming malignant cell-based mechanisms of resistance to immune checkpoint blockade antibodies
Ajina, R., Zahavi, D. J., Zhang, Y., & Weiner, L. M. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.12.005 · Cited by 18
“It is plausible that inhibition of the DNA repair signaling pathway would sensitize tumor cells to antibodybased immunotherapy, providing the rationale for this combination therapeutic strategy [56,57].”
BackgroundArming cytotoxic lymphocytes for cancer immunotherapy by means of the NKG2D/NKG2D-ligand system
Lazarova, M., Wels, W. S., & Steinle, A. (2020) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2020.1803273 · Cited by 18
Yang, Y. J., Park, J. C., Kim, H. K., Kang, J. H., & Park, S. Y. (2013) · PubMed · Cited by 18
Regulation of NKG2D ligands: a purposeful but delicate affair
Spies, T. A. (2008) · Nature Immunology · doi:10.1038/ni0908-1013 · Cited by 18
Biological characteristics of γδT cells and application in tumor immunotherapy
Zhu, R., Yan, Q., Wang, Y., & Wang, K. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2022.1077419 · Cited by 20
“Oxaliplatin, a platinum drug for the treatment of gastric cancer, can upregulate the expression of NKG2D in tumor cells, thereby enhancing the sensitivity of tumor cells to kill mediated by γδT cells, NK cells, or cytokine-induced killer (CIK) cells (Gasser et al., 2005).”
BackgroundNatural killer cell membrane manipulation for augmented immune synapse and anticancer efficacy
Ryu, M., Kim, E., Kim, S., & Kim, K. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.101965 · Cited by 22
Nagasaki, E., Takahara, A., Koido, S., Sagawa, Y., Aiba, K., Tajiri, H., Yagita∥, H., & Homma, S. (2010) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3181d36726 · Cited by 17
“A rabbit anticaspase 8 p18 polyclonal antibody (pAb) (H-134) and a rabbit anticaspase 9 pAb (1-134) were purchased from Santa Cruz Biotechnology (Santa Cruz, CA) and Calbiochem (Darmstadt, Germany), respectively.”
MethodZhang, H., Hardamon, C. R., Sagoe, B., Ngolab, J., & Bui, J. D. (2010) · Molecular Immunology · doi:10.1016/j.molimm.2010.10.015 · Cited by 19
“For example, increased MULT1, RAE, and MICA/B transcripts can be found in cells undergoing DNA damage (Gasser et al., 2005), but it is not known whether H60a is induced by similar signals.”
BackgroundInfluentialHiršl, L., Brizić, I., Jenuš, T., Lisnić, V. J., Reichel, J. J., Jurković, S., Krmpotić, A., & Jonjić, S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00991 · Cited by 17
“However, upon cellular stress caused by infection or cell transformation, their expression increases leading to NKG2D engagement and activation of immune cells (11, 12).”
BackgroundPredictive and Prognostic Value of DNA Damage Response Associated Kinases in Solid Tumors
Gachechiladze, M. A., Škarda, J., Bouchalová, K., Soltermann, A., & Joerger, M. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.581217 · Cited by 17
“It has also been demonstrated that NK cell ligand NKG2D is upregulated in response to DNA damage and ATM is directly involved in its upregulation (22).”
BackgroundEngineered cells as glioblastoma therapeutics
Ramanathan, A., & Lorimer, I. A. J. (2021) · Cancer Gene Therapy · doi:10.1038/s41417-021-00320-w · Cited by 19
Xie, H., Wang, W., Qi, W.-C., Jin, W., & Xia, B. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.661115 · Cited by 17
“The cytosolic DNA-mediated cGAS–STING pathway promotes the reshaping of the immune environment, thus making tumor cells more sensitive to be killed by immune cells (63, 64).”
BackgroundArina, A., Murillo, O., Hervás‐Stubbs, S., Azpilikueta, A., Dubrot, J., Tirapu, I., Huarte, E., Alfaro, C., Perez‐Gracia, J. L., González‐Aseguinolaza, G., et al. (2007) · International Journal of Cancer · doi:10.1002/ijc.22795 · Cited by 19
Self-citationAketa, H., Tatsumi, T., Kohga, K., Tsunematsu, H., Aono, S., Shimizu, S., Kodama, T., Nawa, T., Shigekawa, M., Hikita, H., et al. (2013) · International Journal of Cancer · doi:10.1002/ijc.28118 · Cited by 17
“Gasser et al.21 previously reported that DNA-damaging agents and DNA-synthesis inhibitors including 5-FU could induce the expression of NKG2D ligands on tumor cells.”
BackgroundHennessy, R. J., Pham, K., Delconte, R. B., Rautela, J., Hodgkin, P. D., & Huntington, N. D. (2019) · Journal of Leukocyte Biology · doi:10.1002/jlb.ma0718-296r · Cited by 17
Zwirner, N. W., Fuertes, M. B., Girart, M. V., Domaica, C. I., & Rossi, L. E. (2006) · Cited by 20
DNA damage, inflammation and aging: Insights from mice
Arvanitaki, E. S., Stratigi, K., & Garinis, G. A. (2022) · Frontiers in Aging · doi:10.3389/fragi.2022.973781 · Cited by 17
Vomstein, K., Egerup, P., Kolte, A. M., Behrendt-Møller, I., Boje, A. D., Bertelsen, M.-L. M. F., Eiken, C. S., Reiersen, M. R., Tóth, B., Freiesleben, N. L. C., et al. (2023) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2023.03.018 · Cited by 17
Kang, J. S., & Dervan, P. B. (2015) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583515000104 · Cited by 16
Protective Mechanisms Against DNA Replication Stress in the Nervous System
Charlier, C. F., & Martins, R. A. P. (2020) · Genes · doi:10.3390/genes11070730 · Cited by 17
“The disruption of replication forks and/or DNA repair processes may induce the accumulation of cytoplasmic DNA (either dsDNA, micronuclei, or “speckles”, ssDNA foci less aggregated than micronuclei), triggering the synthesis of cytokines and the activation of immune responses [19,20,80,337].”
BackgroundMicroenvironmental modulation of the developing tumour: an immune‐stromal dialogue
Jones, J. O., Moody, W. M., & Shields, J. D. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12773 · Cited by 18
Modulation of immune responses by DNA damage signaling
Uchihara, Y., Permata, T. B. M., Sato, H., & Shibata, A. (2021) · DNA repair · doi:10.1016/j.dnarep.2021.103135 · Cited by 16
TGF-β, T-cell tolerance and immunotherapy of autoimmune diseases and cancer
Li, M. O., & Flavell, R. A. (2006) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2.2.257 · Cited by 18
Imaoka, T., Ishii, N., Kawaguchi, I., Homma‐Takeda, S., Doi, K., Daino, K., Nakanishi, I., Tagami, K., Kokubo, T., Morioka, T., et al. (2016) · International Journal of Radiation Biology · doi:10.3109/09553002.2016.1152413 · Cited by 16
“Stimulation of natural killer cells also inhibits colon carcinogenesis in mice (Baten et al. 1989), an interesting observation given that irradiated cells express surface proteins that are targeted by natural killer cells (Gasser et al. 2005).”
BackgroundXu, X., Rao, G., & Li, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.11042 · Cited by 16
“DNA damage by exposure to radiation and genotoxic drugs induces NKG2D ligand expression in tumor and fibroblast cells [13, 15, 16].”
BackgroundWang, Y., Wang, C., Xiao, H., Niu, C. S., Wu, H., Jin, H., Cheng, Y., He, H., Tian, H., Han, F., et al. (2016) · Cancer Medicine · doi:10.1002/cam4.942 · Cited by 16
“Interestingly, current adjuvant chemotherapy for treatment of GC patients is based on 5fluorouracil in combination with oxaliplatin, which is known to upregulate the expression of natural killer group 2, member D (NKG2D) in tumor cells, and thereby increase their susceptibility to NK, γδT, or CIK cellmediated killing…”
BackgroundNKG2D‐ligands: Putting everything under the same umbrella can be misleading
Campos‐Silva, C., Kramer, M. K., & Valés‐Gómez, M. (2018) · HLA · doi:10.1111/tan.13246 · Cited by 18
“NKG2D-ligands are commonly found on tumour cells and it has been shown that NKG2D-ligand upregulation can be influenced by ATM/ATR-dependent signalling in response to DNA damage.(55,56) Indeed, drugs affecting the processes of DNA repair and maintenance are often able to modulate the expression of NKG2D-ligands.”
BackgroundLi, H. K., Hasegawa, S., Nakajima, N. I., Morokoshi, Y., Minegishi, K., & Nagatsu, K. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.10.157 · Cited by 16
Okita, R., Maeda, A., Shimizu, K., Nojima, Y., Saisho, S., & Nakata, M. (2019) · Oncology Reports · doi:10.3892/or.2019.7185 · Cited by 16
Distinct pattern of human Vdelta1 gammadelta T cells recognizing MICA.
Li, J., Cui, L., & He, W. (2005) · PubMed · Cited by 24
Oxidative DNA Damage in the Prostate May Predispose Men to a Higher Risk of Prostate Cancer
Wu, J. D., Lin, D. W., Page, S. T., Lundgren, A. D., True, L. D., & Plymate, S. R. (2009) · Translational Oncology · doi:10.1593/tlo.08217 · Cited by 16
“[15] have shown that induced expression of MIC was associated with DNA damage in cells.”
BackgroundDamage-induced IL-18 stimulates thymic NK cells limiting endogenous tissue regeneration
Granadier, D., Cooper, K., Acenas, D. D., II, Kousa, A. I., Warren, M., Hernandez, V. A., Iovino, L., DeRoos, P. C., Lederer, E. E., Shannon-Sevillano, S., et al. (2025) · Nature Immunology · doi:10.1038/s41590-025-02270-z · Cited by 17
Competition for H2A.Z underlies the developmental impacts of repetitive element de-repression
Meng, F. W., Murphy, K. E., Makowski, C. E., Delatte, B., & Murphy, P. J. (2023) · Development · doi:10.1242/dev.202338 · Cited by 15
Characterization of human natural killer cells for therapeutic use
Wagner, A. K., Alici, E., & Lowdell, M. W. (2019) · Cytotherapy · doi:10.1016/j.jcyt.2018.11.001 · Cited by 18
Yu, C., You, M., Zhang, P., Zhang, S., Yin, Y., & Zhang, X. (2021) · Cancer Medicine · doi:10.1002/cam4.3986 · Cited by 15
Li, X., Huang, J., Wu, Q., Du, Q., Wang, Y., Huang, Y., Cai, X., Geller, D. A., & Yan, Y. (2023) · Cancers · doi:10.3390/cancers15030850 · Cited by 15
“The previous study showed that NKG2D ligands were induced by DNA damage [17,18].”
BackgroundResultAdoptive Cell Therapy for Sarcoma
Mata, M., & Gottschalk, S. M. (2015) · Immunotherapy · doi:10.2217/imt.14.98 · Cited by 15
Hirose, W., Horiuchi, M., Li, D., Motoike, I. N., Zhang, L., Nishi, H., Taniyama, Y., Kamei, T., Suzuki, M., Kinoshita, K., et al. (2022) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2022.09.004 · Cited by 16
NK Cell‐mediated Destruction of Influenza A Virus‐infected Peripheral but not Central Neurones
Backström, E., Ljunggren, H., & Kristensson, K. (2007) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2007.01912.x · Cited by 15
General Principles of Tumor Immunotherapy: Basic and Clinical Applications of Tumor Immunology
Kaufman, H. L., & Wolchok, J. D. (2007) · Springer eBooks · doi:10.1007/978-1-4020-6087-8 · Cited by 18
Gismondi, A., & Santoni, A. (2006) · Birkhäuser Basel eBooks · doi:10.1007/3-7643-7442-x_6 · Cited by 15
“These ligands are mainly expressed on the surface of tumor cells of different histotypes, and infected or stressed cells, and are induced in response to DNA damage [10] .”
Hong, X., Lü, L., Künert, B., Naredla, R., Applequist, S. E., Grandien, A., & Glas, R. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4094 · Cited by 17
“21). Activation of PIKKs also mediates expression of cell surface NKG2D ligands ( 41 ).”
BackgroundRetractedDNA-damaged podocyte-CD8 T cell crosstalk exacerbates kidney injury by altering DNA methylation
Nakamichi, R., Hishikawa, A., Chikuma, S., Yoshimura, A., Sasaki, T., Hashiguchi, A., Abe, T., Tokuhara, T., Yoshimoto, N., Nishimura, E. S., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112302 · Cited by 15
Soluble MICA is elevated in pancreatic cancer: Results from a population based case‐control study
Onyeaghala, G. C., Nelson, H. H., Thyagarajan, B., Linabery, A. M., Panoskaltsis‐Mortari, A., Gross, M. D., Anderson, K. E., & Prizment, A. E. (2017) · Molecular Carcinogenesis · doi:10.1002/mc.22667 · Cited by 15
Cédile, O., Popa, N., Pollet-Villard, F., Garmy, N., Ibrahim, E. C., & Boucraut, J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013466 · Cited by 15
“RAE-1 is overexpressed in tumor cell lines [1,4,5] and its expression is induced after viral infection [6,7] and genotoxic stress [8].”
BackgroundAverdam, A., Seelke, S., Grützner, I., Rosner, C., Roos, C., Westphal, N., Stahl‐Hennig, C., Muppala, V., Schrod, A., Sauermann, U., et al. (2007) · Immunogenetics · doi:10.1007/s00251-006-0187-1 · Cited by 14
“Recently, it has been suggested that NKG2D ligands are upregulated by genotoxic stress that indicates the presence of DNA damage to the immune system (Gasser et al. 2005; Gasser and Raulet 2006).”
BackgroundEnhancing non-coding RNA information content with ADAR editing
Laurent, G. S., Savva, Y. A., & Reenan, R. A. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.09.009 · Cited by 14
Cancer Chemotherapy and Immune Regulation
Barrett, J. A., & Blanc, K. L. (2009) · American Journal of Immunology · doi:10.3844/ajisp.2009.8.16 · Cited by 14
“The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor.”
BackgroundMutations in components of antiviral or microbial defense as a basis for breast cancer
Friedenson, B. (2013) · Functional & Integrative Genomics · doi:10.1007/s10142-013-0336-1 · Cited by 16
“The DNA damage response may also participate in alerting the immune system to the presence of potentially dangerous cells (Gasser et al. 2005)”
BackgroundThe influence of radiation in the context of developing combination immunotherapies in cancer
Honeychurch, J., & Illidge, T. (2017) · Therapeutic Advances in Vaccines and Immunotherapy · doi:10.1177/2051013617750561 · Cited by 14
MG132 selectively upregulates MICB through the DNA damage response pathway in A549 cells
Luo, D., Dong, X., Yan, B., Liu, M., Xue, T., Liu, H., Jun-hao, Y., Li, F., Wang, Z., & Chen, Z. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.9676 · Cited by 15
“The expression levels of NKG2D ligands are increased in tumor cells compared with those in the surrounding normal tissue (21), which can be induced further by cancer treatment agents (30,31).”
Innate Tumor Immune Surveillance
Smyth, M. J., Swann, J. B., & Hayakawa, Y. (2007) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-34814-8_7 · Cited by 14
Metadata
- Authors
- Gasser, S., Orsulic, S., Brown, E. J., & Raulet, D. H.
- Affiliations
- University of California, Berkeley (US)
- University of Pennsylvania (US)
- Corresponding author
- Raulet, David H.
- Venue
- Nature
- Published
- 2005-07-03
- Volume
- 436
- Issue
- 7054
- Pages
- 1186-1190
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC1352168
- OpenAlex
- W1969464492
- Cited by
- 1,308
- References
- 28
- Citations by year
- 2026: 23 · 2025: 39 · 2024: 26 · 2023: 51 · 2022: 57 · 2021: 60 · 2020: 72 · 2019: 62 · 2018: 62 · 2017: 64 · 2016: 63 · 2015: 71 · 2014: 85 · 2013: 74 · 2012: 68
- FWCI
- 28.11
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Prostate Cancer Foundation
- National Institutes of Health
- National Cancer Institute (R01CA093678)
- National Institute of Allergy and Infectious Diseases (R01AI039642)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Keywords
- NKG2D, NKG2D ligands, DNA damage response, innate immunity, ATM kinase, ATR kinase, Chk1, genotoxic stress, natural killer cells, CD8+ T cells, cancer cell lines, siRNA
- MeSH terms
- Checkpoint Kinase 1, Animals, Cell Transformation, Neoplastic, DNA Damage, DNA Replication, Fibroblasts, Humans, Immune System, Immunity, Innate, Kinetics, Ligands, Mice, Inbred C57BL, Phosphorylation, Protein Kinases, Receptors, Immunologic, Up-Regulation, Aphidicolin, Protein Serine-Threonine Kinases, Cell Cycle Proteins, Cell Line, Tumor, Mice, Receptors, Natural Killer Cell, NK Cell Lectin-Like Receptor Subfamily K, Ataxia Telangiectasia Mutated Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.